Axsome Therapeutics (AXSM) Capital Expenditures Growth (3y) (2018 - 2026)
Axsome Therapeutics (AXSM) Capital Expenditures Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Axsome Therapeutics |
12.84 Bn |
12.54 Bn |
176.48 Mn |
19.45% |
| Date | Value |
|---|
| Mar 31, 2026 |
19.45% |
| Dec 31, 2025 |
-26.80% |
| Sep 30, 2025 |
-4.22% |
| Jun 30, 2025 |
-62.22% |
| Mar 31, 2025 |
16.46% |
| Dec 31, 2024 |
305.18% |
| Sep 30, 2024 |
-29.67% |
| Jun 30, 2024 |
40.18% |
| Mar 31, 2024 |
48.39% |
| Dec 31, 2023 |
-29.86% |
| Sep 30, 2023 |
192.37% |
| Jun 30, 2023 |
353.29% |
| Mar 31, 2023 |
96.69% |
| Dec 31, 2022 |
398.51% |
| Sep 30, 2022 |
174.35% |
| Sep 30, 2021 |
212.44% |
| Jun 30, 2021 |
25.11% |
| Mar 31, 2021 |
27.20% |
| Dec 31, 2020 |
2,627.34% |
| Sep 30, 2020 |
60.31% |
